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Introduction
Mass lesions in the cerepellopontine angle (CPA) are not 
easily differentiated based on clinical symptoms and physi-
cal examination. Asymmetric sensorineural hearing loss is 
most commonly associated with vestibular schwannomas 
(VS), as they arise directly from the sheath of  the vestibular 
nerve in the internal auditory canal (IAC). However, men-
ingiomas and other mass lesions that affect the vestibulo-
cochlear nerve along its cisternal or intracannalicular 
course may present in a similar manner to VS. Differentia-
tion of  these lesions is important because it alters clinical 
decision-making and treatment planning.
Magnetic resonance imaging (MRI) provides an essential 
means for characterizing and distinguishing CPA mass le-
sions. Knowledge of  classic imaging features such as lesion 
shape and the presence or absence of  adjacent hyperostosis, 
calcification, or a dural tail can increase diagnostic specific-
ity and confidence. Our case illustrates how asymmetric 
sensorineural hearing loss resulting from a CPA mass lesion 
with classic imaging features for VS may be directly treated 
with stereotactic radiosurgery.
Case report
A 71-year-old man presented with a two-year history of  
progressive left-sided hearing loss. Though hearing loss had 
been gradual, he was unable at presentation to use a phone 
with his left ear or hear people talking to him if  they were 
standing to his left. He denied any history of  head trauma, 
otologic surgery, or occupational noise exposure. He also 
denied tinnitus or vertigo. An MRI performed for evalua-
tion of  asymmetric sensorineural hearing loss revealed an 
extra-axial ice-cream-cone-shaped mass in the left CPA, 
centered at the porus acousticus and extending into the 
fundus of  the IAC. The mass was isointense to brain on 
T1- and T2-weighted images. Postcontrast images demon-
strated uniform enhancement of  the mass without evidence 
of  a dural tail. The imaging appearance was classic for a 
VS (Fig. 1, A-D).
Treatment options for VS were discussed. Due to the 
patient’s age, the relatively small size of  the tumor, and an 
estimated less-than-50% chance of  preserving hearing on 
the affected side from skull-base microsurgery, the patient 
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elected to undergo treatment with stereotactic radiosurgery. 
The lesion was treated by gamma knife with 12 Gray deliv-
ered to the 50% isodose surface. On followup MRI three 
months after radiotherapy, the lesion appeared slightly 
larger with new areas of  nonenhancement centrally, consis-
tent with necrosis (Fig. 2A). Followup MRI approximately 
three years after treatment showed slight interval decrease 
in size of  the tumor as compared to the pretreatment base-
line MRI (Fig. 2B).
Discussion
Vestibular schwannomas typically arise from Schwann 
cells lining the inferior vestibular nerve. Formerly called 
acoustic neuromas, these benign tumors are the most 
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Figure 1. 71-year-old man with asymmetric sensorineural hearing loss. Contrast-enhanced MRI of the brain and IACs. Axial 
precontrast T1- (A) and T2-weighted (B) images show an ice-cream-cone-shaped mass centered in the left porus acousticus 
that is isointense to brain parenchyma. Axial (C) and coronal (D) postcontrast fat-suppressed T1-weighted images show avid 
enhancement of the lesion, without evidence of a dural tail. The findings are characteristic of a vestibular schwannoma (white 
arrows). 
common mass lesions in the CPA, accounting for 70% to 
80% of  all masses in this region and 8% to 10% of  intrac-
ranial tumors overall (1, 2). The tumor most often presents 
in the fifth and sixth decades of  life (3). Postmortem exami-
nation reveals an incidence of  2.7%, though the actual in-
cidence in clinical practice is much lower, suggesting that 
most VS are completely asymptomatic (4). Symptomatic 
patients typically present with unilateral sensorineural hear-
ing loss, tinnitus, and/or disequilibrium. VS are commonly 
seen in patients with neurofibromatosis type 2 (NF 2), a 
phakomatosis related to a mutation on chromosome 22 in 
which patients have multiple schwannomas, meningiomas, 
and ependymomas. Bilateral VS are diagnostic of  NF 2.
Like the other common lesions in the CPA region, such 
as meningiomas and epidermoid cysts, VS are extra-axial 
masses. While the classic ice-cream-cone-shaped VS in-
volves the IAC (cone) with extension into the CPA cistern 
(ice-cream scoop), isolated intracanalicular and purely in-
tracisternal lesions can also occur. Purely intracisternal 
schwannomas are typically much larger at presentation, 
likely because they have more room to grow before becom-
ing symptomatic. Large, purely intracisternal schwannomas 
can cause mass effect on the brainstem, fourth ventricle, 
and cerebellum, leading to presenting symptoms other than 
hearing loss (5).
Contrast-enhanced MRI is the method of  choice for im-
aging tumors of  the CPA, including VS. According to the 
schema of  Bonneville et al. (6, 7), enhancing lesions are 
divided by anatomic compartment: intra-axial, extra-axial, 
and skull-base. Extra-axial contrast-enhancing lesions ac-
count for 80% to 95% of  CPA masses. Of  these, VS is by 
far the most common CPA tumor, accounting for over two-
thirds of  all such cases.
Dedicated MR imaging protocols for evaluation of  CPA 
masses (or other causes of  retrocochlear pathology in the 
setting of  asymmetric sensorineural hearing loss) generally 
consist of  precontrast T1- and T2-weighted images, post-
contrast T1 with fat suppression, and thin-section T2-
weighted MR cisternography (8, 9). Typical imaging char-
acteristics for VS include a soft-tissue mass in the CPA/IAC 
that is isointense to brain on precontrast T1 and hyperin-
tense on standard T2, though hypointense on MR cister-
nography. Schwannomas typically enhance strongly, though 
more heterogeneous enhancement and even cystic compo-
nents are often seen with larger lesions (10, 11). On CT, VS 
appear isodense to brain parenchyma on noncontrast im-
ages, with enhancement on postcontrast images. VS involv-
ing the IAC can remodel the porus acusticus, particularly if 
large.
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Figure 2. 71-year-old man with asymmetric sensorineural hearing loss. Serial followup contrast-enhanced, T1-weighted, fat-
suppressed axial MRI sequences obtained after gamma knife radiosurgery. The left-sided vestibular schwannoma (white ar-
rows) shows slight interval enlargement with central nonenhancement of the cisternal component at three months post-
treatment (A), consistent with early post-treatment changes expected after stereotactic radiosurgery. Three years after 
gamma-knife treatment (B), the lesion has not increased in size; the size of the cisternal component is slightly decreased 
compared to the pretreatment baseline scan (Fig. 1C, above).
Differentiating VS from other common CPA lesions, such 
as meningiomas, is important because the treatment and 
operative approach can differ (12). Clinical signs and symp-
toms are unreliable, as the clinical triad of  sensorineural 
hearing loss, tinnitus, and disequilibrium has only 10% 
specificity for VS , with most CPA meningiomas also pre-
senting with hearing loss (13). Imaging plays a key role in 
differentiating these two entities. CT can be helpful, as 25% 
to 36% of  meningiomas have intratumoral calcification, a 
rare finding in schwannomas. Meningiomas can cause hy-
perostosis of  the adjacent bone, whereas VS erode or widen 
the IAC. On MRI, a “dural tail sign,” indicating enhance-
ment of  thickened peritumoral dura, is most characteristic 
of  meningiomas (12). 
Additional MRI sequences may provide further informa-
tion that can increase diagnostic specificity and confidence 
in difficult cases. On T2*-weighted GRE images, intrale-
sional microhemorrhages are highly specific for VS (14). 
Diffusion-weighted MR imaging is unreliable in differenti-
ating the two; while mean ADC values tend to be higher in 
VS than meningiomas, there is significant overlap (15). In 
challenging cases, more advanced imaging techniques such 
as perfusion-weighted MR imaging and MR spectroscopy 
can play a role. Using dynamic susceptibility-weighted 
perfusion-MR imaging, the relative cerebral blood volume 
(rCBV) ratio of  VS (3.23 +/- 0.81) is significantly lower 
than meningiomas (8.02 +/- 3.89), though some overlap 
can exist (16). With MR spectroscopy, meningiomas charac-
teristically show the presence of  an alanine peak at 1.5 
ppm, while schwannomas lack the alanine peak and instead 
show the presence of  myo-inositol at 3.55 ppm (17).
Once the diagnosis of  VS is established, imaging plays a 
key role in both treatment planning and followup. Treat-
ment strategies include watchful waiting, radiotherapy, and 
surgery, and multiple clinical variables factor into the initial 
mode of  treatment, including the age of  the patient, coex-
isting conditions, hearing status in both ears, patient and 
physician preference, and NF 2 status (18). The primary 
goal of  treatment is to control tumor growth, though sec-
ondary aims include minimizing symptoms and complica-
tions. Evidence-based guidelines comparing the different 
treatment modalities are lacking, and both patient prefer-
ence and physician bias often play a strong role in treat-
ment decision-making (19). While VS growth rate tends to 
be slow, the actual growth rate among individual cases is 
variable. Furthermore, tumor size does not always correlate 
with symptoms. A greater likelihood of  future growth is 
seen in larger lesions, younger patients, an extracanalicular 
location, and documented prior growth (20, 21).
Watchful waiting is often a reasonable initial strategy for 
older individuals, for patients with comorbidities that make 
them poor surgical candidates, and for small tumors. Typi-
cally, these patients will have audiovestibular symptoms 
monitored regularly as well as serial MR examinations (of-
ten once per year) to assess for growth (22). While followup 
examinations are traditionally performed with pre- and 
post-contrast images, a recent study suggests that noncon-
trast MR cisternography or similar thin-slice T2 MRI may 
be sufficient for following lesion size (23). While lesion size 
is generally assessed in two dimensions, recent evidence 
suggests that volume quantification may be more accurate 
for followup (24).
Imaging plays a key role in planning for radiotherapy or 
surgery, and can help with creating radiotherapy treatment 
fields or determining the surgical approach. Relevant vari-
ables include tumor size, relation to the facial nerve, and 
intralabyrinthine signal intensity. While nonoperative ap-
proaches are often used for small tumors, surgery is indi-
cated for lesions greater than 3 centimeters (19). MR cis-
ternography and postcontrast sequences can be helpful to 
delineate the facial nerve relative to the schwannomas (25). 
Demonstration of  low signal on T2 within the the labyrinth 
contents is also important for treatment planning, as it pre-
dicts a poor prognosis for hearing following treatment (26). 
Imaging also plays a role with followup after treatment. 
While the success rate of  gamma-knife therapy for control-
ling tumor growth is in the 90% range (27), there will be 
patients whose disease continues to worsen after treatment. 
In our reported case, the patient was treated with gamma-
knife therapy, and has no evidence of  tumor growth after 3 
years. 
VS are among the most common intracranial tumors, 
and imaging plays a key role in diagnosis, treatment plan-
ning, and followup. Classic imaging features of  VS allow 
them to be distinguished from other common CPA masses 
in many cases. Treatment planning decisions for vestibular 
schwannomas may therefore hinge on imaging findings 
together with clinical information, as in the case presented 
here. VS treated with stereotactic radiosurgery require 
post-treatment assessment with serial MRI scans, which 
may show characteristic changes on early post-treatment 
scans followed by either lack of  growth or decreased size in 
most cases. In cases where CPA mass-lesion imaging find-
ings are less definitive, additional MRI imaging methods 
including T2*-weighted sequences, MR spectroscopy, and 
MR perfusion may be helpful to increase diagnostic 
specificity.
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